Alexis Desieno Sells 24,778 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CFO Alexis Desieno sold 24,778 shares of Cardlytics stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $84,245.20. Following the transaction, the chief financial officer now directly owns 140,948 shares in the company, valued at approximately $479,223.20. This trade represents a 14.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Alexis Desieno also recently made the following trade(s):

  • On Friday, January 3rd, Alexis Desieno sold 8,854 shares of Cardlytics stock. The shares were sold at an average price of $3.67, for a total transaction of $32,494.18.

Cardlytics Trading Down 7.4 %

NASDAQ CDLX opened at $3.12 on Thursday. The company’s fifty day simple moving average is $3.45 and its 200-day simple moving average is $3.72. Cardlytics, Inc. has a 52 week low of $2.76 and a 52 week high of $20.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The stock has a market cap of $158.56 million, a P/E ratio of -0.51 and a beta of 1.54.

Analyst Upgrades and Downgrades

CDLX has been the topic of a number of recent research reports. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a research report on Friday, January 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Cardlytics has an average rating of “Hold” and an average price target of $6.92.

Get Our Latest Stock Report on CDLX

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in CDLX. Atom Investors LP acquired a new position in shares of Cardlytics during the third quarter worth $33,000. Tallon Kerry Patrick acquired a new stake in Cardlytics in the fourth quarter valued at $37,000. ProShare Advisors LLC acquired a new stake in Cardlytics in the fourth quarter valued at $43,000. SG Americas Securities LLC acquired a new stake in Cardlytics in the third quarter valued at $45,000. Finally, Intech Investment Management LLC acquired a new stake in Cardlytics in the third quarter valued at $47,000. 68.10% of the stock is owned by institutional investors and hedge funds.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Recommended Stories

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.